Rossari Biotech Ltd vs Shreyas Intermediates Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 18, 2026

Key Highlights

The Latest Trading Price of Rossari Biotech Ltd is ₹ 434.3 as of 18 Mar 11:42 . The P/E Ratio of Rossari Biotech Ltd changed from 67.2 on March 2021 to 24.5 on March 2025 . This represents a CAGR of -18.27% over 5 yearsThe P/E Ratio of Shreyas Intermediates Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Rossari Biotech Ltd changed from ₹ 5388 crore on March 2021 to ₹ 3344 crore on March 2025 . This represents a CAGR of -9.10% over 5 yearsThe Market Cap of Shreyas Intermediates Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 years The revenue of Rossari Biotech Ltd for the Dec '25 is ₹ 582.59 crore as compare to the Sep '25 revenue of ₹ 588.18 crore. This represent the decline of -0.95% The revenue of Shreyas Intermediates Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Rossari Biotech Ltd for the Dec '25 is ₹ 69.78 crore as compare to the Sep '25 ebitda of ₹ 74 crore. This represent the decline of -5.7% The ebitda of Shreyas Intermediates Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Rossari Biotech Ltd changed from ₹ 34.9 crore to ₹ 32.77 crore over 7 quarters. This represents a CAGR of -3.53% The net profit of Shreyas Intermediates Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The Dividend Payout of Rossari Biotech Ltd changed from 3.28 % on March 2021 to 2.41 % on March 2025 . This represents a CAGR of -5.98% over 5 yearsThe Dividend Payout of Shreyas Intermediates Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Rossari Biotech Ltd

Rossari Biotech Limited was founded in 2003 as a partnership firm in the name of Rossari Labtech by Mr. Edward Walter Menezes, and Mr. Sunil Srinivasan Chari, who are both career-technocrats cumulatively having over 45 years of experience in the specialty chemicals industry.
It was further renamed to Rossari Biotech Limited and converted into a company in 2009.
The Company has two state-of-the art facilities at Dahej, Gujarat and Silvassa, Dadra Nagar & Haveli and is mainly engaged in manufacturing, selling and distribution of specialty chemicals.
The products cater to global brands in the FMCG sector and find applications in a host of consumer-centric products and home and personal care products, textile chemicals, animal health and nutrition and cosmetic products. During the FY2020, 50,00,000 equity shares of face value of Rs 10 each was sub-divided into 2,50,00,000 Equity Shares of face value of Rs 2 each.

About Shreyas Intermediates Ltd

Shreyas Intermediates Limited (SIL) was incorporated as a Private Limited Company on November 6, 1989 and subsequently converted into a Public Limited Company in April, 1992.
The Company was promoted by Dinesh S Sharma.
The Company is engaged in manufacturing of Dyes, Pigments and Pigment Intermediates. In Dec.'93, the company came out with its initial public offering, aggregating Rs 3.29 Cr, to diversify into the manufacture of Copper Phthalocyanine Blue Crude and Copper Phthalocyanine Green, with a capacity of 540 TPA and 321 TPA respectively.
The estimated cost of the project was Rs 8.60 Cr.
Both the products have good export potential especially in the US and Germany. The products of SIL find application in the manufacture of plastic colours, direct colours, inks, rubber paints and in the paint industry.

FAQs for the comparison of Rossari Biotech Ltd and Shreyas Intermediates Ltd

Which company has a larger market capitalization, Rossari Biotech Ltd or Shreyas Intermediates Ltd?

Market cap of Rossari Biotech Ltd is 2,343 Cr while Market cap of Shreyas Intermediates Ltd is 47 Cr

What are the key factors driving the stock performance of Rossari Biotech Ltd and Shreyas Intermediates Ltd?

The stock performance of Rossari Biotech Ltd and Shreyas Intermediates Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Rossari Biotech Ltd and Shreyas Intermediates Ltd?

As of March 18, 2026, the Rossari Biotech Ltd stock price is INR ₹423.15. On the other hand, Shreyas Intermediates Ltd stock price is INR ₹6.77.

How do dividend payouts of Rossari Biotech Ltd and Shreyas Intermediates Ltd compare?

To compare the dividend payouts of Rossari Biotech Ltd and Shreyas Intermediates Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.